LUNGevity Foundation shared a post on LinkedIn:
“What if lung cancer biomarker results didn’t have to take weeks?
The UTOPIA pilot study shows they don’t have to. By optimizing workflow and communication, teams delivered comprehensive NSCLC biomarker results within 72 hours for 100% of patients.
Workflow and communication improvements, not new technology, were the main drivers of success in identifying NSCLC biomarker-positive patients so results were available before treatment decisions are made – critical for patient outcomes.
This is the latest essential reading on biomarker testing in NSCLC that LUNGevity added to our regularly updated Clinical Value of Biomarker Testing Web Page, maintained for providers and hospital admin on what’s happening with biomarker testing in NSCLC right now.
Find this article in the ‘Operational Improvement’ section of the website.”
Other articles about Lung Cancer on OncoDaily.